Hello, I already updated the price, can you please help me with my final paper? I need it for today at night the latest. thank you.

I need to review and fix all comments of the paper, it has to be graduate quality work.

Final Paper Ivan A. Primak Embry - Riddle Aeronautical University MBAA 518 - Managerial Finance Instructor: Dr. Al Rodriguez September 28, 2015 Commented [ARP1]: Ivan, you are using simple, sortworded sentences. Please try to be more explicit and support all ascertions with the source. Try to write a more comprehensive report, with more detail. Do not just indicate something without also providing the support. Make sure to label all trables properly as per APA. Add more substance to the paper. Thanks, Al Commented [ARP2]: Hyphenate and use full University name Running Head: Final Paper- Pfizer Inc. 1 Profitability Pfizer Inc. has huge profitability ratios of the order of 80% as gross profit margin and around 25% as net profit margin. Commented [ARP3]: So what does this mean in terms of importance and why? The company is highly profitable. As compared to the competitor, GlaxoSmithKline, they are Commented [ARP4]: Highly is a subjective, be more specific with the facts and support why it is so. much better. For GSK same ratios are 70% and 17%. Commented [ARP5]: Better can only be explained with capitalization. Hence, Pfizer is much better than the competitor in terms of the profitability. Commented [ARP6]: How is profitability defined? Why is it much better? Gross profit margin Net Profit Margin 80.79% 24.70% 70.13% 17.27% Commented [ARP7]: Label the tables. Use column labels. Commented [ARP8]: How do CF's compare with GSK? Cash Flows For Pfizer: Total cash flow from operating activities: 17,054,000 Net Income is just: 14,570,000 Net Income 14,570,000 Depreciation 7,611,000 Adjustments To Net Income -3,213,000 Changes In Accounts Receivables 275,000 Changes In Liabilities -2,859,000 Changes In Inventories -631,000 Changes In Other Operating Activities 1,273,000 Total Cash Flow From Operating Activities 17,054,000 Commented [ARP9]: Why only operating activities? What about investing and financing? Running Head: Final Paper- Pfizer Inc. 2 There are many adjustments that need to be done from net income to calculate total cash flow from Commented [ARP10]: If there are many, why only talk about depreciation? Which are the others? operating activities. First, all the non-cash activities, such as depreciation, must be added like back Then all the adjustments would be done. After that change in the assets and liabilities like PPE, receivables, payables, etc. would be added or subtracted to get the final cash flow. Liquidity and Capital Structure: Current ratio Quick Ratio 2.15 1.58 0.99 0.67 Pfizer has a good advantage in terms of the liquidity. The company is highly liquid given the current and quick ratios. The current ratio for the company is more than 2. Even after deleting the inventory part to calculate the quick ratio as 1.58. It clearly signifies that the company would be able to meet all the obligations even in the worst case scenario of inventory stalling. Even if inventory does not get sold off, they will be able to meet all the liabilities fully and after that they will have 50% left. Comparing with GSK, Pfizer is in a much better situation. For GSK, both the ratios are less than 1. That means they won't be able to meet the obligations in the short term. They need to raise the capital from somewhere to pay for the liabilities. Capital Structure DE ratio 0.46 Commented [ARP11]: What does 2.15 mean in relationship to others in the industry? What is the difference between 2.15 and 0.99? Same for the quick ratio. Running Head: Final Paper- Pfizer Inc. 3 DE Ratio for the company is just 0.46. That means for every $1 of equity they have a liability of Commented [ARP12]: Need to define it before initials can be used. Also, should probably be D/E. less than half a dollar. Approximately 31.5% is debt and rest is equity. This is a good mix of capital. Commented [ARP13]: This number does not agree with the previous statement. This mix clearly illustrates less financial risk for the company. Commented [ARP14]: Write using complete sentences. Also, with 31.5% debt and 68.5% equity. DE for GSK is greater than 253. They have huge debt as compared to the equity they have Make sure that you check these numbers. invested. There is a huge risk for the company to operate. Once bad time starts, the company will Commented [ARP16]: Define what shis means. face a lot of problems. Commented [ARP15]: Unclear antecedent. Commented [ARP17]: Define what is meant by this. Commented [ARP18]: Define what this means. Stock recommendation As of september 28, 2015, Currently Pfizer is trading at around $32.90. There are many factors that support investment in the company: Commented [ARP19]: If the paper is read one year from today, it is no longer currently, therefore, say something like. As of the MMDDYYYY the stock is rading at $xx.xx Return on Equity is around 18% and it is estimated to grow further, giving the shareholders much higher returns. They have a good dividend policy; hence for a person looking for liquidity, this is Commented [ARP20]: Which are these factors? Also consider future trends Commented [ARP21]: Support with facts and figures. a good stock. Pfizer's dividend was cut in 2009, but has increased annually since then. Pfizer has Commented [ARP22]: Define why it is a good dividend policy. been paying dividends since 1980 and has not missed one since then. The revenue is set to increase Commented [N23R22]: following the major breakthrough and the new patents that the company received recently. This makes this company more attractive. At the time when the industry is struggling to keep the profitability, Pfizer has not only been able to maintain market share but also maintained the trust among the consumers. Therefore, it is strongly recommended to buy stocks of Pfizer. Running Head: Final Paper- Pfizer Inc. 4 References Pfizer Financial Reports. (n.d.). Retrieved September 26, 2015, from http://www.pfizer.com/investors/financial_reports/financial_reports Pfizer Inc. (n.d.). Retrieved September 26, 2015, from http://www.google.com/finance?q=NYSE:PFE&ei=RXgJVqikNYXCea3woKgL Final Paper Ivan A. Primak Embry - Riddle Aeronautical University MBAA 518 - Managerial Finance Instructor: Dr. Al Rodriguez September 28, 2015 Commented [ARP1]: Ivan, you are using simple, sortworded sentences. Please try to be more explicit and support all ascertions with the source. Try to write a more comprehensive report, with more detail. Do not just indicate something without also providing the support. Make sure to label all trables properly as per APA. Add more substance to the paper. Thanks, Al Commented [ARP2]: Hyphenate and use full University name Running Head: Final Paper- Pfizer Inc. 1 Profitability Pfizer Inc. has huge profitability ratios of the order of 80% as gross profit margin and around 25% as net profit margin. Commented [ARP3]: So what does this mean in terms of importance and why? The company is highly profitable. As compared to the competitor, GlaxoSmithKline, they are Commented [ARP4]: Highly is a subjective, be more specific with the facts and support why it is so. much better. For GSK same ratios are 70% and 17%. Commented [ARP5]: Better can only be explained with capitalization. Hence, Pfizer is much better than the competitor in terms of the profitability. Commented [ARP6]: How is profitability defined? Why is it much better? Gross profit margin Net Profit Margin 80.79% 24.70% 70.13% 17.27% Commented [ARP7]: Label the tables. Use column labels. Commented [ARP8]: How do CF's compare with GSK? Cash Flows For Pfizer: Total cash flow from operating activities: 17,054,000 Net Income is just: 14,570,000 Net Income 14,570,000 Depreciation 7,611,000 Adjustments To Net Income -3,213,000 Changes In Accounts Receivables 275,000 Changes In Liabilities -2,859,000 Changes In Inventories -631,000 Changes In Other Operating Activities 1,273,000 Total Cash Flow From Operating Activities 17,054,000 Commented [ARP9]: Why only operating activities? What about investing and financing? Running Head: Final Paper- Pfizer Inc. 2 There are many adjustments that need to be done from net income to calculate total cash flow from Commented [ARP10]: If there are many, why only talk about depreciation? Which are the others? operating activities. First, all the non-cash activities, such as depreciation, must be added like back Then all the adjustments would be done. After that change in the assets and liabilities like PPE, receivables, payables, etc. would be added or subtracted to get the final cash flow. Liquidity and Capital Structure: Current ratio Quick Ratio 2.15 1.58 0.99 0.67 Pfizer has a good advantage in terms of the liquidity. The company is highly liquid given the current and quick ratios. The current ratio for the company is more than 2. Even after deleting the inventory part to calculate the quick ratio as 1.58. It clearly signifies that the company would be able to meet all the obligations even in the worst case scenario of inventory stalling. Even if inventory does not get sold off, they will be able to meet all the liabilities fully and after that they will have 50% left. Comparing with GSK, Pfizer is in a much better situation. For GSK, both the ratios are less than 1. That means they won't be able to meet the obligations in the short term. They need to raise the capital from somewhere to pay for the liabilities. Capital Structure DE ratio 0.46 Commented [ARP11]: What does 2.15 mean in relationship to others in the industry? What is the difference between 2.15 and 0.99? Same for the quick ratio. Running Head: Final Paper- Pfizer Inc. 3 DE Ratio for the company is just 0.46. That means for every $1 of equity they have a liability of Commented [ARP12]: Need to define it before initials can be used. Also, should probably be D/E. less than half a dollar. Approximately 31.5% is debt and rest is equity. This is a good mix of capital. Commented [ARP13]: This number does not agree with the previous statement. This mix clearly illustrates less financial risk for the company. Commented [ARP14]: Write using complete sentences. Also, with 31.5% debt and 68.5% equity. DE for GSK is greater than 253. They have huge debt as compared to the equity they have Make sure that you check these numbers. invested. There is a huge risk for the company to operate. Once bad time starts, the company will Commented [ARP16]: Define what shis means. face a lot of problems. Commented [ARP15]: Unclear antecedent. Commented [ARP17]: Define what is meant by this. Commented [ARP18]: Define what this means. Stock recommendation As of september 28, 2015, Currently Pfizer is trading at around $32.90. There are many factors that support investment in the company: Commented [ARP19]: If the paper is read one year from today, it is no longer currently, therefore, say something like. As of the MMDDYYYY the stock is rading at $xx.xx Return on Equity is around 18% and it is estimated to grow further, giving the shareholders much higher returns. They have a good dividend policy; hence for a person looking for liquidity, this is Commented [ARP20]: Which are these factors? Also consider future trends Commented [ARP21]: Support with facts and figures. a good stock. Pfizer's dividend was cut in 2009, but has increased annually since then. Pfizer has Commented [ARP22]: Define why it is a good dividend policy. been paying dividends since 1980 and has not missed one since then. The revenue is set to increase Commented [N23R22]: following the major breakthrough and the new patents that the company received recently. This makes this company more attractive. At the time when the industry is struggling to keep the profitability, Pfizer has not only been able to maintain market share but also maintained the trust among the consumers. Therefore, it is strongly recommended to buy stocks of Pfizer. Running Head: Final Paper- Pfizer Inc. 4 References Pfizer Financial Reports. (n.d.). Retrieved September 26, 2015, from http://www.pfizer.com/investors/financial_reports/financial_reports Pfizer Inc. (n.d.). Retrieved September 26, 2015, from http://www.google.com/finance?q=NYSE:PFE&ei=RXgJVqikNYXCea3woKgL